Zhang, Y.; Wang, J.; Wang, C.; Li, Z.; Liu, X.; Zhang, J.; Lu, J.; Wang, D.
Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis. Int. J. Mol. Sci. 2018, 19, 1527.
https://doi.org/10.3390/ijms19051527
AMA Style
Zhang Y, Wang J, Wang C, Li Z, Liu X, Zhang J, Lu J, Wang D.
Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis. International Journal of Molecular Sciences. 2018; 19(5):1527.
https://doi.org/10.3390/ijms19051527
Chicago/Turabian Style
Zhang, Yongfeng, Jiaqi Wang, Chunyue Wang, Zhiping Li, Xin Liu, Jun Zhang, Jiahui Lu, and Di Wang.
2018. "Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis" International Journal of Molecular Sciences 19, no. 5: 1527.
https://doi.org/10.3390/ijms19051527
APA Style
Zhang, Y., Wang, J., Wang, C., Li, Z., Liu, X., Zhang, J., Lu, J., & Wang, D.
(2018). Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis. International Journal of Molecular Sciences, 19(5), 1527.
https://doi.org/10.3390/ijms19051527